Autophagy: A new treatment strategy for MSC-based therapy in acute kidney injury (Review)

Mol Med Rep. 2018 Mar;17(3):3439-3447. doi: 10.3892/mmr.2017.8311. Epub 2017 Dec 19.

Abstract

Acute kidney injury (AKI) is a common and serious medical condition associated with poor health outcomes. Autophagy is a conserved multistep pathway that serves a major role in many biological processes and diseases. Recent studies have demonstrated that autophagy is induced in proximal tubular cells during AKI. Autophagy serves a pro‑survival or pro‑death role under certain conditions. Furthermore, mesenchymal stem cells (MSCs) have therapeutic potential in the repair of renal injury. This review summarizes the recent progress on the role of autophagy in AKI and MSCs‑based therapy for AKI. Further research is expected to prevent and treat acute kidney injury.

Keywords: autophagy; acute kidney injury; mesenchymal stem cells; cell death.

MeSH terms

  • Acute Kidney Injury / pathology
  • Acute Kidney Injury / therapy*
  • Adenine / analogs & derivatives
  • Adenine / therapeutic use
  • Animals
  • Autophagy*
  • Humans
  • Mesenchymal Stem Cell Transplantation*
  • Mesenchymal Stem Cells / cytology
  • Mesenchymal Stem Cells / metabolism
  • MicroRNAs / metabolism
  • Reperfusion Injury / pathology
  • Reperfusion Injury / prevention & control
  • TOR Serine-Threonine Kinases / metabolism

Substances

  • MicroRNAs
  • 3-methyladenine
  • TOR Serine-Threonine Kinases
  • Adenine